Could antibiotics tame sarcoidosis? new study investigates
NCT ID NCT05291468
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a combination of two antibiotics (azithromycin and doxycycline) can reduce bacteria linked to sarcoidosis and lower inflammation. About 40 adults with biopsy-confirmed sarcoidosis and active inflammation on a PET scan will receive the antibiotics or a placebo. The goal is to see if targeting the bacteria improves disease activity and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Antonius Hospital
Nieuwegein, Utrecht, 3435 CM, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Can immune profiling unlock the hidden stages of tuberculosis?
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Home devices may spot lung flare-ups before they become emergencies
- Could a monthly shot beat daily pills for lung sarcoidosis?
- Massive study tracks lung disease progression in 4,000 patients